USPTO trademark

PROTAGONIST THERAPEUTICS

AllowedUSPTOWord markClass 5Class 42Class 44

"PROTAGONIST THERAPEUTICS" is a word mark owned by Protagonist Therapeutics, Inc., filed at the USPTO on March 3, 2023. It has been allowed and covers classes 5, 42 and 44.

View Protagonist Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
PROTAGONIST THERAPEUTICS trademark as filed
As filed with the USPTO
Status
Allowed
Since July 22, 2026
Filed
March 3, 2023
Registered
Not yet
Expires
Not recorded
Application no.
97822178
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns PROTAGONIST THERAPEUTICS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Protagonist Therapeutics, Inc.

PTGX · Newark, United States

9 trademarks in the portfolioView company

Representative

Melissa A. Nowak

Christensen O'Connor Johnson Kindness

Goods and services

What the mark covers

The products and services PROTAGONIST THERAPEUTICS is filed for, grouped by Nice class.

  • Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of metabolic disorders

  • Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders; Scientific research, pharmaceutical research, medical research; technical consultation services in the field of research and product development for the treatment of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; scientific consultation services in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; product development services for others in the fields of immune mediated diseases, inflammatory diseases, oncological disorders and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, oncological and rare diseases

  • Providing healthcare information to healthcare professionals and patients relating to disease states and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 5 granted
  3. Case assigned to intent to use paralegal
  4. Sou extension 5 filed
  5. Sou teas extension received
  6. Teas withdrawal of attorney received-firm retains
  7. Teas change of correspondence received
  8. Attorney/dom.rep.revoked and/or appointed
  9. Teas revoke/app/change addr of atty/dom rep received
  10. Notice of approval of extension request e-mailed

10 earlier steps on the official record.

FAQ

About PROTAGONIST THERAPEUTICS

Who owns the trademark "PROTAGONIST THERAPEUTICS"?

The USPTO trademark "PROTAGONIST THERAPEUTICS" (application 97822178) is owned by Protagonist Therapeutics, Inc.

What is the status of "PROTAGONIST THERAPEUTICS"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PROTAGONIST THERAPEUTICS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b70-b2bb-7643-86f7-41b02e3b689d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b70-b2bb-7643-86f7-41b02e3b689d",
  "object": "trademark",
  "mark_text": "PROTAGONIST THERAPEUTICS",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97822178",
  "filing_date": "2023-03-03",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "PROTAGONIST THERAPEUTICS, INC.",
      "entity_id": "ent_019eb715-aaa5-750e-ab80-0f081fc9e674"
    }
  ]
}